Disease Info Card

Renal Cell Carcinoma

Information about Renal Cell Carcinoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Renal Cell Carcinoma

Most recent studies have shown that Renal Cell Carcinoma shares some biological mechanisms with adenocarcinoma, adenocarcinoma-clear-cell, carcinoma, cell-invasion, conventional-(clear-cell)-renal-cell-carcinoma, hemorrhage, kidney-diseases, kidney-neoplasm, lung-neoplasms, malignant-neoplasm-of-kidney, malignant-neoplasms, malignant-paraganglionic-neoplasm, melanoma, metastatic-renal-cell-cancer, neoplasm-invasiveness, neoplasm-metastasis, neoplasms, neoplasms-multiple-primary, pain, von-hippel-lindau-syndrome.

Among the many pathways, these few ones have gauged particular interests from scientists studying Renal Cell Carcinoma, and have been seen in publications frequently: Angiogenesis, Cell Adhesion, Cell Cycle, Cell Death, Cell Growth, Cell Proliferation, Coagulation, Drug Resistance, Enucleation, Excretion, Glomerular Filtration, Hypersensitivity, Immune Response, Localization, Methylation, Oncogenesis, Pathogenesis, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Renal Cell Carcinoma, such as CA9, CTLA4, EGFR, FH, HIF1A, IFNA1, IFNG, IL2, IL6, MME, MTOR, MUC1, SLC25A5, TNF, TP53, VEGFA, VHL, VIM, XRCC1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.